Bone Biologics Corp (BBLG)
CIK 1419554 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bone Biologics Corp.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 26, 2026 | 10-Q | 0001493152-26-048571 |
| Oct 13, 2026 | 25-NSE | 0001354457-26-000978 |
| Sep 30, 2026 | 4 | 0001493152-26-045149 |
| Sep 30, 2026 | 4 | 0001493152-26-045147 |
| Sep 30, 2026 | 4 | 0001493152-26-045135 |
| Sep 30, 2026 | 4 | 0001493152-26-045140 |
| Sep 29, 2026 | 8-K | 0001493152-26-044889 |
| Sep 16, 2026 | 8-K | 0001493152-26-042940 |
| Aug 28, 2026 | DEF 14A | 0001493152-26-040640 |
| Aug 18, 2026 | PRE 14A | 0001493152-26-039034 |
| Aug 14, 2026 | 10-Q | 0001493152-26-038482 |
| Jul 24, 2026 | EFFECT | 9999999995-26-002449 |
| Jul 24, 2026 | 424B3 | 0001493152-26-034605 |
| Jul 23, 2026 | 8-K | 0001493152-26-034334 |
| Jul 20, 2026 | DEFA14A | 0001493152-26-033938 |
| Jul 17, 2026 | S-3 | 0001493152-26-033789 |
| Jul 16, 2026 | 8-K | 0001493152-26-033586 |
| Jul 9, 2026 | 8-K | 0001493152-26-032694 |
| Jul 2, 2026 | DEF 14A | 0001493152-26-031652 |
| Jul 2, 2026 | ARS | 0001493152-26-031654 |
| Jul 2, 2026 | DEFA14A | 0001493152-26-031653 |
| May 14, 2026 | 10-Q | 0001493152-26-023163 |
| Mar 13, 2026 | 8-K | 0001493152-26-010080 |
| Mar 13, 2026 | 424B5 | 0001493152-26-010072 |
| Mar 2, 2026 | 10-K | 0001493152-26-008564 |